JC virus (JCV), the causative agent of the fatal human demyelinating disease progressive multifocal leukoencephalopathy (PML), is an opportunistic papovavirus that infects and destroys oligodendrocytes, the myelin-producing cells of the central nervous system. Since its isolation from the brain of a PML patient, JCV has long been classed as a neurotropic virus. Many studies, however, have demonstrated that JCV can infect various other cell types, including immune system cells. Moreover, several recent studies have focused specifically on lymphocytes as a target of JCV. This review chronicles the association of JCV with lymphocytes, including cell type localization, molecular regulation, and viral sequences, and discusses clinical implications of these findings. . These authors, using signs and symptoms of PML result from the viral destruction Southern blot analysis for JCV DNA and indirect immunofluoof myelin-producing oligodendrocytes in the central nervous rescence for virion capsid and large T antigen, investigated the system (CNS). The cardinal pathologic features of PML include extraneural tissue distribution of JCV in postmortem specimens multiple foci of myelin and oligodendroglial cell loss, hyperfrom 10 patients with PML. Although JCV proteins could not chromatic enlarged oligodendroglial nuclei, and bizarre astrocytes be detected in any extraneural tissues investigated, JCV DNA with enlarged multilobulated nuclei. Initial areas of demyelination was detected in liver, lung, lymph node, and spleen tissues are small and multiple but usually progress, with coalescing foci from 2 children with severe combined immunodeficiency syndeveloping into lesions several centimeters in diameter. The drome and in lung tissue from an adult patient with Hodgkin's widespread and multifocal distribution of the demyelinating ledisease. Although the cell type(s) responsible for harboring sions suggests a hematogenous viral spread to the CNS.
The opportunistic polyomavirus, JC virus (JCV), is the etiowith PML [6] . Here we chronicle the association of JCV with lymphocytes, with emphasis on cell type localization, gene logic agent of the subacute human demyelinating disease, progressive multifocal leukoencephalopathy (PML) (reviewed in regulation, and viral sequence assessment. [1, 2] ). Classically, PML presents as a triad of symptoms: visual deficits, motor weakness, and altered mental state [3] . Less frequently, PML patients may display speech dysfunction, JCV Association with Lymphocytes cerebellar disorders, sensory deficits, extrapyramidal synPerhaps the first association of JCV DNA with lymphocytes dromes, headache, seizures, and vertigo [1, 3] . The neurologic was suggested by Grinnell et al. [7] . These authors, using signs and symptoms of PML result from the viral destruction Southern blot analysis for JCV DNA and indirect immunofluoof myelin-producing oligodendrocytes in the central nervous rescence for virion capsid and large T antigen, investigated the system (CNS). The cardinal pathologic features of PML include extraneural tissue distribution of JCV in postmortem specimens multiple foci of myelin and oligodendroglial cell loss, hyperfrom 10 patients with PML. Although JCV proteins could not chromatic enlarged oligodendroglial nuclei, and bizarre astrocytes be detected in any extraneural tissues investigated, JCV DNA with enlarged multilobulated nuclei. Initial areas of demyelination was detected in liver, lung, lymph node, and spleen tissues are small and multiple but usually progress, with coalescing foci from 2 children with severe combined immunodeficiency syndeveloping into lesions several centimeters in diameter. The drome and in lung tissue from an adult patient with Hodgkin's widespread and multifocal distribution of the demyelinating ledisease. Although the cell type(s) responsible for harboring sions suggests a hematogenous viral spread to the CNS.
JCV was not identified in these PML patients, the tissues con-JCV was originally cultivated by inoculating primary human taining JCV DNA have circulating lymphocytes that could have fetal glial cells (HFGC) with postmortem brain extracts derived been the source of the viral DNA. from a PML patient (initials J.C.) [4] . HFGC remain the most
The first report demonstrating JCV in lymphocytes came susceptible host cell for JCV, which has led to the classification in 1988. Houff et al. [6] described the presence of JCV DNA of this papovavirus as neurotropic. As such, much of the celluand virion capsid antigen in bone marrow mononuclear cells lar and molecular biology of JCV has been studied in glial isolated from 2 PML patients. In the first patient, who also cells. Over the years, many studies have demonstrated that JCV had AIDS, JCV DNA and capsid antigen were found in bone can infect various other cell types (reviewed in [5] ). Recently, marrow mononuclear cells by in situ hybridization and immulymphocytes have become a cell type of interest in JCV biology nocytochemistry, respectively. In the second patient, who with the demonstration of JCV infection of B cells in patients was reported to have no underlying immunosuppression, JCV DNA and capsid antigen were found in mononuclear cells from bone marrow aspirates and biopsy specimens. These
Together, these data provided the first evidence that JCV can amplification followed by Southern blot analysis, detected JCV sequences in bone marrow mononuclear cells in patients infect mononuclear cells and, more specifically, B lymphocytes. Since this original description, JCV has been demonwith leukemia before and after bone marrow transplantation. Additionally, Katz et al. [11] , using in situ hybridization, strated in lymphocytes present in the bone marrow, CNS, and peripheral blood (table 1) .
detected JCV DNA in bone marrow biopsy specimens from a 15-year-old boy with PML complicating Wiskott-Aldrich Several studies have detected JCV DNA in mononuclear cells in the bone marrow and the CNS [8 -11] . Tornatore et syndrome. Moreover, Major et al. [8] , using in situ hybridization, reported the presence of JCV DNA in mononuclear al. [9] , using in situ hybridization, demonstrated the presence of JCV DNA in mononuclear cells isolated from the bone cells in brain tissue from a PML patient. These JCV-positive cells were shown to be B lymphocytes (CD45R / cells) by marrow in 5 (31%) of 16 PML patients. A study by Schneider and Dorries [10] , using polymerase chain reaction (PCR) dual-labeling techniques. Because JCV has been detected in lymphocytes present in strated in a few cases, and in fact, another report indicated that JCV may be present in both B and non-B cells [20] . Indeed, both bone marrow aspirates and biopsies [6, 9 -11] as well as in brain specimens [6, 8] , it is not surprising that JCV has also larger studies are necessary to further define the lymphotropic specificity of JCV. been detected in peripheral blood lymphocytes (PBL) [9, 11, 12 -15] . Tornatore et al. [9] utilized PCR amplification folIn contrast to the above reports, there have been a number of studies unable to detect JCV DNA in PBL or PBMC [17 - lowed by Southern blot analysis to investigate the presence of JCV DNA in PBL and reported JCV DNA in 17 (89%) of 19 19]. Using PCR amplification and Southern blotting, Quinlivan et al. [17] could not detect JCV DNA in 10 peripheral blood PML patients, 17 of whom also had AIDS. In this study, the presence of JCV was also investigated in 2 other patient populaspecimens from HIV-1 -positive patients. Sundsfjord et al. [18] were unable to detect JCV DNA The presence of JCV DNA in lymphocytes isolated from bone marrow, brain, or peripheral blood does not address chronic lymphocytic leukemia and simultaneous PML, diffuse cerebral leukemic parenchymal infiltration, and latent Epsteinwhether or not JCV can productively infect these cells. In fact, the presence of DNA replication and capsid antigen is only Barr virus (EBV) cerebral coinfection. Using PCR amplification followed by either Southern blot analysis or a liquid phase suggestive of a productive infection. In vitro experiments, however, have shown that JCV is indeed capable of productively hybridization assay, Dubois et al. [14] ) by flow cytometry and analyzed human fetal liver were also susceptible to JCV infection. KG-1 cells can be differentiated into mature macrophages upon for the presence of JCV by PCR amplification followed by Southern blot analysis. JCV DNA was detected in the unsorted phorbol ester treatment. These differentiated macrophages and the promonocytic cell line, U937, were not susceptible to JCV PBMC and the sorted B cell subpopulations from the PML patient; there was no JCV DNA in the T cell population from infection. These data support the lymphoid cell susceptibility observed in the various studies discussed above. Monaco et al. the PML patient and none in the T, B, or unsorted population from the non-PML patient. This study not only demonstrates
[16] also demonstrated that primary B cells (CD19 / ) isolated from both peripheral blood and tonsillar tissues were susceptithat JCV is present in lymphocytes but also corroborates previous studies [6, 8] , suggesting that there may be a subpopulation ble to JCV infection as well. Moreover, the KG-1a, primary CD34 / cells, and primary B lymphocytes were all shown to of lymphocytes, specifically B cells, with which JCV associates. Although these studies [6, 8, 16] was active in B lymphocytes and glial cells but not in T lymphocytes. Mutation of the TGGC repeats not only abolished have a greater rate of JCV infectivity (Ç20%) than B cells, which could be attributed to the expression of specific transcripbinding to this region but also decreased the activity of this region. These experiments suggest that the interaction of this tion factors, such as class B nuclear factor-1 (NF-1), that increase efficiency of viral replication (Major EO et al., unpub- factor with the regulatory region of JCV is of functional significance in the expression of JCV in both B lymphocytes and lished observations). The significance of tonsillar stromal cell infection in the pathogenesis of PML is addressed in the discusglial cells. sion.
Sequences in Lymphocytes Molecular Regulation in Lymphocytes
Unlike most of the viral genome, the promoter/enhancer region of JCV differs among the various isolates [24] . On the Since HFGC are the most susceptible host cell for JCV, most studies focusing on the molecular regulation of this virus have basis of the differences within the viral regulatory region, JCV has been classified into several types: types I, II, and archetype involved glial cells (reviewed in [22] [21] , using DNase I slightly from one another but share several features. The control region of type II strains lacks the distal TATA sequence and footprint analysis, demonstrated that nuclear proteins present in two B lymphocytic cell lines (Namalwa and LyT3) protected usually contains a 23-bp GC-rich insertion within the proximal repeat. The Mad-4 JCV strain differs from this classification; the same sequences within the JCV regulatory region as proteins present in glial cells. The significance of this finding, it has a deletion in the TATA sequence but lacks the 23-bp insertion usually found in type II strains. Types I and II gehowever, is clouded by the observation that nuclear extracts from HeLa cells also protected the same region of JCV. Using nomes have been isolated from both the brain and urine of PML patients. Other types of JCV genomes, types III and IV, electrophoretic mobility shift assays (EMSAs) with the same regulatory sequence of JCV, Atwood et al. [21] demonstrated have been described [27, 28 ]. An ''archetype'' JCV genome has also been described [29] , which consists of a single 98-bp that the gel shift patterns from nuclear extracts obtained from both B cell lines were similar to one another but distinct from repeat with the 23-bp GC-rich insert and a second 66-bp insert. Archetype genomes have been isolated from the urine of many the pattern observed with HeLa nuclear extract. Competition analysis using an oligonucleotide containing an NF-1 binding patients, including renal transplant patients [29] , pregnant women [30] , and AIDS patients [31] . Because this JCV strain site specifically eliminated a single complex present in both B cell extracts but competed for a different complex in the HeLa contains all of the elements found in both type I and II genomes, it has been postulated that all rearranged types of JCV are cell extract. Likewise, a mutated NF-1 oligonucleotide failed to compete for the formation of any complexes obtained with adaptations of this archetype strain [29] .
There have been several types of JCV detected in lymphoeither B cell extract but did compete for a complex obtained with the HeLa cell extract. These experiments suggest that cytes [9, 12, 15] . Tornatore et al. [9] sequenced the regulatory region of JCV isolated from peripheral lymphocytes of 3 pathere may be factors common to both glial and B cells that interact with the regulatory region of JCV.
tients, 2 of whom were PML patients with AIDS; the third was a JCV-positive HIV-1 -seropositive patient without PML. The Rieckmann et al.
[23] also investigated the presence of a factor present in both glial and B cells. Using EMSAs with an prototype Mad-1 strain (type I) was found in 1 PML patient with AIDS, a Mad-4 strain was found in the second PML oligonucleotide derived from the regulatory region of JCV (nt 130 -160, domain B), specific bands of the same mobility were patient with AIDS, and a Mad-4 strain with a 1-nucleotide transversion was found in the JCV-positive HIV-1 -seroposidetected in nuclear extracts from human fetal glial cells, U-251 glioma cells, a B cell line (BJAB), and in vitro -activated tive patient without PML. Dorries et al. [12] reported the sequence of the regulatory region of JCV isolated from PBL of tonsillar B lymphocytes but not from T lymphocytes. Additionally, a specific shift was detected in nuclear extracts from pri-6 immunocompetent patients. In all cases, the sequence was that of Mad-1 (type I): one had a 4-bp insertion and two others mary tonsillar or lymph node B cells from 5 AIDS patients.
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10-30-97 12:15:23 jinfa UC: J Infect had 3 point mutations. Azzi et al. [15] reported the presence The relationship between JCV and lymphocytes is strengthened by observations from other polyomaviruses. of both rearranged types as well as archetype JCV sequences in PBL. Although this study used restriction enzyme digestion BK virus (BKV), although isolated from urinary tract epithelial cells, has also been shown to be lymphotropic. In fact, to classify the genomes of JCV in the lymphocytes, it is noteworthy in light of the fact that archetype genomes are almost the presence of virus receptors was demonstrated on human peripheral B lymphocytes [37] . Moreover, BKV has also exclusively found in kidney tissue and urinary JCV isolates.
been shown to replicate in human lymphocytes isolated from peripheral blood [38] . Of interest, similar to the case with Discussion and Clinical Implications JCV, BKV was unable to replicate in human monocytes isolated from peripheral blood [38] . Seroepidemiologic studies demonstrate that infection with JCV is very common and usually occurs during childhood. In
Another polyomavirus, hamster polyomavirus, has also been shown to infect lymphocytes. In fact, hamster polyomavirus fact, ú80% of the human adult population is seropositive for JCV -specific antibodies [32, 33] . Despite this high prevalence induces lymphomas and leukemia in newborn hamsters [39, 40] . Moreover, large amounts of extrachromosomal viral geof infection, JCV-induced disease is rare, occurring almost exclusively in individuals with immune suppression [1] . Benomes are present in the lymphoma cells [41, 42] . These observations pose interesting questions with respect to the oncogenic cause of these observations, JCV is thought to establish a latent infection and become reactivated upon immune suppression potential of JCV. JCV has been shown to cause neuroectodermal tumors in [5] . Lymphocytes offer attractive candidates for JCV latency and reactivation. Studies summarized here support the ability rodents and nonhuman primates [43 -50] . -56] . Nonetheless, the the many underlying diseases associated with PML that are characterized by polyclonal lymphocyte activation [1, 34, 35] . ability of JCV to transform both human and nonhuman cells in vitro is described [57 -59]. Moreover, Neel et al. [60] demActivated lymphocytes can cross the blood-brain barrier without requiring antigen recognition at the cerebrovascular endoonstrated that infection of HFGC with JCV produces polyploidy and chromosomal damage. thelial surface. These findings provide a means by which activated JCV-infected B lymphocytes could enter the brain and
The oncogenic potential of JCV is noteworthy with respect to the background in which PML develops. PML is usually in turn permit JCV to lytically infect oligodendrocytes, inducing CNS demyelination. Moreover, the presence of replicating associated with immunocompromised conditions. The majority of PML cases occur in AIDS patients. In fact, Ç4% of all JCV DNA in perivascular cells and B lymphocytes in the brains of PML patients [6, 8] provides in vivo evidence that JCV AIDS patients will develop this neurodegenerative disease [61] . HIV-1 -infected persons are not only prone to developing inreplication in B lymphocytes may be a necessary, if not sufficient, event in the pathogenesis of PML.
fectious opportunistic diseases but are also at risk of developing a variety of neoplastic diseases. Among the neoplastic diseases The proposed infection of the CNS by JCV-infected B lymphocytes is not without precedent. Viral infection and replicathat occur with an increased frequency in HIV-1 -infected persons are Kaposi's sarcoma and non-Hodgkin's lymphoma. tion in hematogenous cells is well known. Virus-infected mononuclear cells are believed to be a source of infection of the AIDS-associated lymphomas are usually a late manifestation of HIV-1 infection with CD4 T cell counts õ200 cells/mm 3 . CNS in a number of nervous system diseases including those caused by HIV, cytomegalovirus, and EBV. Results presented It is interesting to note that most of these lymphomas are B cell in origin. The most common types include large cell here suggest B lymphocytes infected with JCV may be another mononuclear cell infection that leads to CNS infection.
immunoblastic, small noncleaved cell (Burkitt's), and large cell cleaved or noncleaved. There are many pathogenetic mechaThe observation that human tonsillar stromal cells can be infected with JCV raises interesting speculations about the prinisms proposed to explain AIDS-associated lymphomas, including EBV infection as well as alterations in protooncogenes mary infection. If primary infection occurs via a respiratory route, perhaps tonsillar stromal cells, because of their relatively and/or tumor suppressor genes. Despite these numerous proposed mechanisms, a significant number of AIDS-associated higher susceptibility to JCV infection (only 2.5 times less susceptible that HFGC), could be the initial cell type JCV infects.
lymphomas are yet unexplained. Given the existence of JCV in B cells, the ability of JCV to Moreover, stromal cells are a major component of lymphoid tissues within the body and have been shown to interact with replicate within and productively infect B cells, and the oncogenic potential of JCV, it is tempting to envision a participatory B lymphocytes [36] . Thus, tonsillar stromal cells could also provide a reservoir for lymphocyte infection, which could seed role for JCV (and/or BKV) in AIDS-associated B cell lymphomas. This is interesting in light of the recent observation that the bone marrow and other lymphoid organs.
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